Porton Pharma Solutions Ltd.

Global contract development and manufacturing organisation working to GMP. It covers small molecules, peptides and oligonucleotides, biologics and antibody-drug conjugates, and cell and gene therapies. Its Changshou plant in Chongqing occupies 235,527 square metres with reactors from 5 to 10,000 litres, and it reports inspections passed by China, the FDA, Japan, the WHO and the European agency.